Workflow
Earnings Preview: Hess (HES) Q1 Earnings Expected to Decline
ZACKS· 2025-04-23 23:07
Hess (HES) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30. On the othe ...
Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2025-04-23 23:07
Wall Street expects a year-over-year increase in earnings on higher revenues when Humana (HUM) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on April 30, 2025, might help the stock move higher if these key numbers are better than expectation ...
Illinois Tool Works (ITW) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-04-23 23:07
Wall Street expects a year-over-year decline in earnings on lower revenues when Illinois Tool Works (ITW) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on April 30, 2025, might help the stock move higher if these key numbers are better than ...
Analysts Estimate Warrior Met Coal (HCC) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-04-23 23:07
The market expects Warrior Met Coal (HCC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be release ...
Amazon's Earnings Could Fuel a Rapid Breakout
MarketBeat· 2025-04-23 23:02
文章核心观点 - 亚马逊股价虽周二上涨3.5%,但较2月高点仍下跌30%且跑输标普500;虽华尔街看好,估值有吸引力,但AWS业务有谨慎信号,宏观不确定性影响情绪,下周财报或成股价走势催化剂 [1][2][9] 股价表现 - 周二收盘价略高于173美元,涨幅3.5%,为多个交易日最佳表现,但较2月历史高点下跌30%,在市场近期反弹中跑输标普500 [1] - 股价维持在4月7日低点之上,但未吸引大量买家,交易区间收窄,买卖盘僵持 [2] 华尔街评级 - 多家机构重申买入或同等评级,加拿大丰业银行目标价250美元,较周二收盘价有超40%上涨空间 [2] - 摩根士丹利仍将亚马逊列为首选股,维持增持评级,虽下调2026年每股收益预测至7美元,目标价降至245美元 [3] 估值优势 - 亚马逊2026年GAAP市盈率为23倍,低于沃尔玛的32倍,分析师认为宏观逆风使投资者转向沃尔玛,忽视了亚马逊的AI潜力和零售、云业务的利润率提升空间 [5] - 亚马逊规模使其在关税上升环境中有优势,若贸易紧张影响小玩家,亚马逊有望扩大市场份额 [6] 业务担忧 - 亚马逊网络服务(AWS)暂停部分数据中心租赁讨论,尤其是国际业务,虽不致命,但影响高利润率业务的发展预期 [7] - 宏观不确定性,如高利率、贸易担忧和对大型科技股的谨慎态度,影响市场情绪,使亚马逊股价缺乏动力 [9] 财报影响 - 亚马逊下周公布财报,若业绩超预期,可能引发空头回补和机构兴趣;若不及预期,可能加剧当前低迷态势 [10][11] - 目前股价处于2020年水平,多空僵持,财报或带来明确方向 [11]
Amazon's Starlink competitor runs into production delays
TechCrunch· 2025-04-23 23:01
In Brief Amazon’s Project Kuiper, the company’s initiative to launch a fleet of satellites into low-Earth orbit and beam internet connection to users, is struggling to ramp up production, Bloomberg reported on Wednesday.The competitor to Elon Musk’s Starlink has completed only a few dozen satellites, according to the report. The venture reportedly needs to quadruple its rate of production in order to meet a government deadline, which requires the company to launch 1600 satellites into space by next summer. ...
PANW Plunges 11% in a Month: Should You Hold or Fold the Stock?
ZACKS· 2025-04-23 23:00
Palo Alto Networks, Inc. (PANW) shares have lost 11.4% in the past month, underperforming the Zacks Security industry’s decline of 9.2% in the same time frame. Palo Alto Networks has also underperformed its industry peers and competitors, including CyberArk (CYBR) , CrowdStrike (CRWD) and Zscaler (ZS) .Palo Alto Networks’ recent decline stems from a broader market weakness. A widespread sell-off in tech stocks, triggered by fears of rising trade tensions and slowing economic growth concerns, has put pressur ...
Amphenol (APH) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2025-04-23 23:00
For the quarter ended March 2025, Amphenol (APH) reported revenue of $4.81 billion, up 47.7% over the same period last year. EPS came in at $0.63, compared to $0.40 in the year-ago quarter.The reported revenue represents a surprise of +13.93% over the Zacks Consensus Estimate of $4.22 billion. With the consensus EPS estimate being $0.52, the EPS surprise was +21.15%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expecta ...
Ford launches exclusive experience program for its priciest pickups
CNBC· 2025-04-23 23:00
Ford is launching a program that aims to give its "Platinum Plus" pickup truck customers a more curated, exclusive experience.DEARBORN, Mich. — Ford Motor is launching a program that aims to give its most premium pickup truck customers a more curated, exclusive experience.The Detroit automaker's new ownership experience is for its "Platinum Plus" customers. The program ranges from offering a personal concierge and virtual tutorial tours to gifts, accessory discounts and a "Ford Protect Premium Maintenance P ...
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of BridgeBio Pharma, Inc. (NASDAQ: BBIO)
Prnewswire· 2025-04-23 23:00
NEW YORK, April 23, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating BridgeBio Pharma, Inc. (NASDAQ: BBIO) on behalf of the company's shareholders.  The investigation seeks to determine whether BridgeBio Pharma's directors breached their fiduciary duties in connection with recent corporate actions.If you are a shareholder of BridgeBio Pharma and are interested in obtaining additional information regarding your rights and options, free of charge, please visit us at: https://pjl ...